Zinc lozenges: cold cure or candy? Solution chemistry determinations
- PMID: 15499830
- PMCID: PMC7087920
- DOI: 10.1023/b:bire.0000037754.71063.41
Zinc lozenges: cold cure or candy? Solution chemistry determinations
Abstract
Common colds were shortened by 7 days in a 1984 clinical trial using zinc gluconate throat lozenges each 2 h. Between then and 2004, 10 other double-blind, placebo-controlled clinical trials showed widely varying results. This re-analysis of these trials presents solution chemistry methods to elucidate differences in efficacy. Statistically significant correlation was shown between total daily dosages of positively charged zinc species and reductions in median (p = 0.005) and mean duration (p < 0.02) of common colds in these trials.
References
-
- Winther B., Gwaltney J. M., Mygind N., Turner R. B., Hendley J. O. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA. 1986;256:1763–1767. - PubMed
-
- Eby, G. A. (1994) Handbook for Curing the Common Cold-The Zinc Lozenge Story, George Eby Research, Austin (http://coldcure.com/html/handbook-for-curing-the-common-cold.html).
-
- Eby G. A. Zinc ion availability-the determinant of efficacy in zinc lozenge treatment of common colds. J. Antimicrob. Chemother. 1997;40:483–493. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical